The International Trade Commission (ITC), once primarily focused on trade-related disputes, has become a critical venue for patent litigation, especially in technology, life sciences, and consumer electronics industries. Its authority to block infringing products from entering the U.S. market makes it an attractive forum for patent holders seeking fast and decisive enforcement.
The ITC operates under Section 337(a) of the Tariff Act of 1930, which prohibits unfair methods of competition and unfair acts in the importation and sale of goods, including patent infringement. Unlike district courts, ITC investigations proceed at a rapid pace, often concluding within 15 to 18 months from the filing of a complaint to a final ruling.
When a Section 337 complaint is filed, the ITC initiates an investigation overseen by an administrative law judge. These proceedings encompass formal discovery, motions, evidentiary hearings, and appeals, mirroring district court litigation in many respects. However, the ITC’s hallmark is its remedy: exclusion orders that bar infringing products from entering the United States.
Monetary damages are not available through the ITC. Instead, if a violation of Section 337 is found, the ITC must issue an exclusion order preventing the importation of infringing articles. Additionally, the ITC can impose cease-and-desist orders to prohibit the sale or use of any commercially significant inventory already imported.
Several factors motivate patent owners to choose the ITC over traditional district court litigation. First, the ITC’s jurisdiction is limited to imported articles, not the parties themselves. This means the accused products must be imported into the U.S. for the ITC to have authority.
Second, the ITC’s reach extends globally without the presumption against extraterritorial application of U.S. law that district courts apply. This allows the ITC to address infringement involving proprietary processes performed abroad, a significant advantage when dealing with foreign manufacturers.
Third, the ITC offers swift and potent remedies. Unlike district courts, which apply a four-factor test before granting injunctive relief, the ITC can issue exclusion and cease-and-desist orders without such a test. The threat of exclusion often pressures defendants into licensing agreements or design modifications.
Fourth, the timeline for ITC investigations is markedly shorter. While district court patent cases typically take three to five years to reach trial, the ITC holds a trial-like evidentiary hearing within eight to ten months of complaint filing, with final determinations commonly issued within 15 to 18 months.
Fifth, the pleading standards in Section 337 investigations require detailed complaints supported by substantial evidence demonstrating harm to a domestic industry. Unlike district courts, the ITC does not permit motions to dismiss based on inadequate factual allegations, making early-stage challenges less common.
A prominent example illustrating the ITC’s impact is the recent dispute between Apple and Masimo over blood oxygen monitoring technology used in Apple Watches. Masimo, a medical technology company, accused Apple of infringing its pulse oximetry sensor patents and brought the case before the ITC.
The ITC ruled in favor of Masimo, issuing an exclusion order that barred the importation of certain Apple Watch models into the U.S. This forced Apple to temporarily halt sales of those models, underscoring the ITC’s ability to disrupt even dominant market players. Apple ultimately circumvented the ruling by modifying its devices to remove the infringing technology.
For patent holders seeking expedited relief and exclusionary remedies, the ITC presents a compelling alternative to district court litigation. This is especially true for patents in technology-intensive sectors such as consumer electronics, pharmaceuticals, and semiconductors, where rapid market impact is critical.
As the ITC continues to assert its role in intellectual property enforcement, understanding its jurisdiction, procedural nuances, and strategic advantages is essential for companies navigating complex patent disputes involving imported goods.
Understanding the Strategic Appeal of ITC Patent Litigation Under Section 337 The International Trade Commission (ITC) has evolved into a pivotal forum for patent enforcement, particularly in technology and life sciences. By leveraging Section 337 of the Tariff Act of 1930, patent owners can secu... Read the full IIPLA article: https://iipla.org/news/understanding-the-strategic-appeal-of-itc-patent-litigation-under-section-337